CMS Coronary Artery Disease Reimbursement 
DAIC
JANUARY 23, 2024
The new code, designated by The American Medical Association ( AMA ), supports FFRCT as the standard of care in assessing patients with suspected coronary artery disease ( CAD ). In the hospital setting, CMS increased payment for the FFRCT service by ~7% for 2024.
DAIC
MARCH 28, 2025
v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.
DAIC
OCTOBER 16, 2024
15 , 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage determinations (LCD) for AI-Coronary Plaque Analysis (AI-CPA). The SCCT HPPC offers tools for administrators to navigate the complex landscape of insurance plans, billing and reimbursement on SCCT website, scct.org.
American College of Cardiology
FEBRUARY 1, 2025
In today's health care landscape, where quality metrics tied to reimbursement have become the standard, clinicians are under increasing pressure to prescribe specific medications. Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease. J Am Geriatr Soc. 2023;71(7): 2052-2081.
DAIC
MARCH 3, 2025
25, 2025 GE HealthCare has delivered the first patient doses of Flyrcado(flurpiridaz F 18) injection, a unit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent for detecting coronary artery disease (CAD), at early adopter imaging centers in the US. tim.hodson Mon, 03/03/2025 - 16:07 Feb.
Expert insights. Personalized for you.
105 
Let's personalize your content